Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nina J. Chu"'
Autor:
Peter Zanvit, Dewald van Dyk, Christine Fazenbaker, Kelly McGlinchey, Weichuan Luo, Jessica M. Pezold, John Meekin, Chien-ying Chang, Rosa A. Carrasco, Shannon Breen, Crystal Sao-Fong Cheung, Ariel Endlich-Frazier, Benjamin Clark, Nina J. Chu, Alessio Vantellini, Philip L. Martin, Clare E. Hoover, Kenesha Riley, Steve M. Sweet, David Chain, Yeoun Jin Kim, Eric Tu, Nathalie Harder, Sandrina Phipps, Melissa Damschroder, Ryan N. Gilbreth, Mark Cobbold, Gordon Moody, Emily E. Bosco
Publikováno v:
The Journal of Clinical Investigation, Vol 133, Iss 22 (2023)
Prostate cancer is generally considered an immunologically “cold” tumor type that is insensitive to immunotherapy. Targeting surface antigens on tumors through cellular therapy can induce a potent antitumor immune response to “heat up” the tu
Externí odkaz:
https://doaj.org/article/e772d4b790a848fcb94aa4259efad645
Autor:
Jacquelyn W. Zimmerman, Elizabeth M. Jaffee, Todd D. Armstrong, Aleksandra Popovic, Bridget P. Keenan, Alexander C. Hopkins, Minwei Cao, Elana J. Fertig, Robert A. Anders, Nina J. Chu
Almost all pancreatic ductal adenocarcinomas (PDA) develop following KRAS activation, which triggers epithelial transformation and recruitment of desmoplastic stroma through additional transcriptional and epigenetic regulation, but only a few of thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::372c7823cf6422082f233f2664b6e472
https://doi.org/10.1158/1940-6207.c.6547637.v1
https://doi.org/10.1158/1940-6207.c.6547637.v1
Autor:
Jacquelyn W. Zimmerman, Elizabeth M. Jaffee, Todd D. Armstrong, Aleksandra Popovic, Bridget P. Keenan, Alexander C. Hopkins, Minwei Cao, Elana J. Fertig, Robert A. Anders, Nina J. Chu
R script of TCGA computational analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac7058146a7ad07ea6bc16860e6af9b3
https://doi.org/10.1158/1940-6207.22534760
https://doi.org/10.1158/1940-6207.22534760
Autor:
Jacquelyn W. Zimmerman, Elizabeth M. Jaffee, Todd D. Armstrong, Aleksandra Popovic, Bridget P. Keenan, Alexander C. Hopkins, Minwei Cao, Elana J. Fertig, Robert A. Anders, Nina J. Chu
Supplementary text
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ddd0c26182bb945fc3810b92cd0dfc5
https://doi.org/10.1158/1940-6207.22534754
https://doi.org/10.1158/1940-6207.22534754
Autor:
Jacquelyn W. Zimmerman, Elizabeth M. Jaffee, Todd D. Armstrong, Aleksandra Popovic, Bridget P. Keenan, Alexander C. Hopkins, Minwei Cao, Elana J. Fertig, Robert A. Anders, Nina J. Chu
Supplementary Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2643c52e67e94f1df9b762eb0566c656
https://doi.org/10.1158/1940-6207.22534757
https://doi.org/10.1158/1940-6207.22534757
Autor:
Nina J. Chu, Michael G. Overstreet, Ryan Gilbreth, Lori Clarke, Christina Gesse, Eric Tu, Gordon Moody, Maria Letizia Giardino Torchia
Publikováno v:
Cancer Research. 82:2837-2837
Background: Hepatocellular carcinoma (HCC) is the most common type of liver cancer and the third leading cause of cancer-related death worldwide. Immune checkpoint inhibitors have been recently approved in the first-line setting, however only 20-30%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce51a115c10522a640b45b7af95bf1d1
https://doi.org/10.1158/1538-7445.am2022-2837
https://doi.org/10.1158/1538-7445.am2022-2837
Autor:
Zanvit, Peter1, van Dyk, Dewald2, Fazenbaker, Christine1, McGlinchey, Kelly1, Weichuan Luo1, Pezold, Jessica M.1, Meekin, John1, Chien-ying Chang2, Carrasco, Rosa A.1, Breen, Shannon1, Crystal Sao-Fong Cheung2, Endlich-Frazier, Ariel2, Clark, Benjamin2, Nina J. Chu1, Vantellini, Alessio3, Martin, Philip L.4, Hoover, Clare E.5, Riley, Kenesha5, Sweet, Steve M.4, David Chain4
Publikováno v:
Journal of Clinical Investigation. 11/15/2023, Vol. 133 Issue 22, p1-17. 17p.
Publikováno v:
Cancer Research. 80:5716-5716
Introduction: Pancreatic ductal adenocarcinoma (PDAC) tumorigenesis is largely driven by an activating KRAS (mKRAS) mutation that is nearly ubiquitous in the earliest stages of disease, pancreatic intraepithelial neoplasias (PanINs). Targeting KRAS d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39deb9bf90ce541f3005bdd5f83ba2c6
https://doi.org/10.1158/1538-7445.am2020-5716
https://doi.org/10.1158/1538-7445.am2020-5716
Publikováno v:
Cancer Research. 78:3778-3778
Immunotherapy agents that activate T cells are changing clinical practice for some metastatic cancer patients. Vaccines targeting viral oncogenes prevent the development of hepatocellular and cervical cancers. We therefore tested the hypothesis that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a00734a6ab9b1b9f7909803b9e33bd37
https://doi.org/10.1158/1538-7445.am2018-3778
https://doi.org/10.1158/1538-7445.am2018-3778